Delivery Order SPE2DB24D2205-SPE2DB24FDVQG
- Not listed
- This federal contract award, with a ceiling value of $32,448.80, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a completion date of May 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The contract is a delivery order with a firm fixed price of $48,673.20 and an ultimate completion date of August 29, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a...
- This federal contract award for $32,448.80 was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, to provide TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of December 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $16,224.40 firm fixed price delivery order is for the supply of Takhzyro 300 mg/2 ml syringes. This contract does not have a set-aside designation and is part of Amerisourcebergen's existing indefinite delivery contract with the DLA to provide pharmaceuticals and medical supplies in...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $34,342.56 and a performance period ending on July 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $31,755.04 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide TAKHZYRO 300 MG/2 ML syringes. Performance will take place in Conshohocken, Pennsylvania over a period spanning from June 28, 2023 through July 20, 2023. The Defense Logistics Agency Troop Support Medical, which supports the medical supply needs of the U.S. Department...
- This federal contract award, valued at $12,990.43, was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, which runs through April 30, 2024, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
- This federal contract award, valued at $46,493.46, was issued to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order that will be delivered on a firm fixed-price basis by June 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to various federal agencies, with a particular focus on...
- This federal contract award to Amerisourcebergen Drug Corp, valued at $28,361.25, is a delivery order contract for the supply of TREMFYA 100 MG/ML syringes. The award was made by the Defense Logistics Agency (DLA), a major defense agency responsible for providing logistics, acquisitions, and technical services to the U.S. military. The contract has a firm fixed price pricing type and an ultimate completion date of October 7, 2024. As a large pharmaceutical distributor, Amerisourcebergen has been...
- This federal contract award, valued at $82,943.40, was issued by the Medical Supply Chain branch of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, will provide a variety of prescription medications, over-the-counter drugs, and medical supplies to support the Department of Defense (DoD)...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDVQGDelivery Order
This federal contract award, valued at $32,448.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a completion date of July 9, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This current contract award is likely a specific order placed against that larger IDC. There is no set-aside designation mentioned for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.4k | 6/14/24 |